Literature DB >> 20862800

[Clinical significance of cellular immune function in patients with viral myocarditis].

Hong-ying Wen1, Wei-kun Jia, Li Liu, Ling Yang, Yan Yang, Xue-mei Sun, Jing Gou, Xiao-yan Zhang, Shu-liang Wei.   

Abstract

AIM: To probe into the clinical significance of cellular immune function in patients with viral myocarditis.
METHODS: Choose our hospital in January 2008-December 2009 admitted during the 75 patients of viral myocarditis as the experimental group, 67 healthy patients served as control groups, respectively, and hospital admission within 24 h after the venous blood, before and after treatment T cell subsets, natural killer cells (NK) activity and tumor necrosis factor (TNF) were detected and analyzed.
RESULTS: Compared with admission, 24 h after admission test in peripheral blood T lymphocyte subsets CD3, CD4, CD8 and CD4/CD8 were improved and CD3, CD4 and CD4/CD8 were statistically significant differences (P<0.05), but still slightly lower in the control group, while the difference was not statistically significant. At the same time, compared with admission, 24 h after admission of natural killer cells in the experimental group (NK) and tumor necrosis factor were improved, the differences were statistically significant (P<0.05), but still slightly lower than the control group, but the difference was not statistically significant.
CONCLUSION: More in-depth study of viral myocarditis in patients with immune injury mechanism will help to better guide the treatment, and has important clinical significance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20862800

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

Review 1.  Necroptosis and Viral Myocarditis: Tumor Necrosis Factor α as a Novel Biomarker for the Diagnosis of Viral Myocarditis.

Authors:  Jin Zhou; Jing Xu; Peng Li; Shan Sun; Yimiti Kadier; Shiying Zhou; Aijuan Cheng
Journal:  Front Cell Dev Biol       Date:  2022-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.